Letter: Vitamin D supplementation and the irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 4, 2013, Pages 499-

  Karaahmet, F ^a   Basar, O ^a   Yksel, I ^a   Coban, S ^a   Yuksel, O ^a  

^a Diskapi Yildirim Beyazit Educational and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

ANXIETY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DEPRESSION; FIBROMYALGIA; FRACTURE; HUMAN; IRRITABLE COLON; LETTER; MAST CELL; OSTEOPOROSIS; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

HUMANS; IRRITABLE BOWEL SYNDROME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84872719425     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12188     Document Type: Letter

References (5)

1. Matricon J, Meleine M, Gelot A, et al,. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012; 36: 1009-31.
2. Ford AC, Talley NJ,. Irritable bowel syndrome. BMJ 2012; 345: 37-42.
3. Spiller R, Aziz Q, Creed F, et al,. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770-98.
4. Stobaugh DJ, Deepak P, Ehrenpreis ED,. Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome. Osteoporos Int 2012; doi: 10.1007/s00198-012-2141-4 [Epub ahead of print].
5. Holick MF,. Vitamin D Deficiency. N Engl J Med 2007; 357: 266-81.